BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | -99.8% | 92 | -99.8% | 0.00% | -100.0% |
| Q2 2022 | $7,656,000 | -50.8% | 52,546 | -59.9% | 0.06% | -38.5% |
| Q1 2022 | $15,555,000 | -27.5% | 131,186 | -15.4% | 0.09% | -17.3% |
| Q4 2021 | $21,446,000 | -11.5% | 155,100 | -11.1% | 0.11% | -17.3% |
| Q3 2021 | $24,228,000 | +40.6% | 174,418 | -1.7% | 0.13% | +25.5% |
| Q2 2021 | $17,231,000 | +110.9% | 177,493 | +48.5% | 0.11% | +96.3% |
| Q1 2021 | $8,170,000 | – | 119,536 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |